{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:36:42Z","timestamp":1783985802502,"version":"3.55.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Chronic pain remains a health problem that is difficult to treat adequately. Its unknown cause and complex comorbidity with other illnesses, including mental disorders, amplify the severity of symptoms, which consequently decreases the quality of life of patients long term. In our clinical practice, we coincidentally found evidence that methylphenidate (MPH) effectively managed chronic pain in an adult patient with attention deficit hyperactivity disorder (ADHD). The effectiveness of MPH in the treatment of ADHD is well-established; however, its utility in treating pain remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present a rare case of a 43-year-old male patient with 15 years of chronic idiopathic pain symptoms that did not adequately respond to standard pain management, such as acetaminophen, non-opioid analgesics, and muscle relaxers. Pain also persisted after treatments with antidepressants and an epidural block. Furthermore, symptoms worsened following several sessions of modified electroconvulsive therapy. After a thorough assessment at our child and adolescent psychiatric outpatient clinic, we confirmed a diagnosis of adult ADHD with a predominantly inattentive type. Considering this newly established diagnosis, we prescribed osmotic-release oral system (OROS) methylphenidate. Within 1 month of treatment at a dose of 18 mg\/day of OROS-MPH, the patient\u2019s chronic pain unexpectedly improved dramatically, and the patient no longer experienced pain symptoms. The dosage of OROS-MPH was titrated monthly, reaching 72 mg\/day as a maintenance dose, and ADHD symptoms improved after 4 months of treatment. The patient was followed up regularly for 7 years during his OROS-MPH treatment. No adverse effects were reported, including stimulant addiction. He was stable overall and functioned well in his daily activities. His pain never recurred.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case report suggests that MPH may be potentially effective in treating chronic pain. Further studies are needed to confirm whether MPH improved chronic pain simultaneously with or separately from the improvement in ADHD. Moreover, elucidating the anatomical sites and molecular pharmacological mechanisms related to the action of MPH in pain modulation and perception is essential. Such sites include the descending dopaminergic pain pathway and higher cortical areas. Furthering our understanding may reinforce the justification for treating chronic pain using MPH.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1091399","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T04:23:31Z","timestamp":1678422211000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Case report: Methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder"],"prefix":"10.3389","volume":"14","author":[{"given":"Ekachaeryanti","family":"Zain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Someya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","article-title":"A classification of chronic pain for ICD-11","volume":"156","author":"Treede","year":"2015","journal-title":"Pain"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1097\/j.pain.0000000000002557","article-title":"A global study of pain prevalence across 52 countries: Examining the role of country-level contextual factors","volume":"163","author":"Zimmer","year":"2022","journal-title":"Pain"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur J Pain"},{"key":"ref4","article-title":"Psychiatric comorbidities in chronic pain syndromes","volume-title":"Pain management: A problem-based learning approach","author":"Beckman","year":"2018"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jpain.2015.06.009","article-title":"Comorbidity of mental disorders and chronic pain: chronology of onset in adolescents of a National Representative Cohort","volume":"16","author":"Tegethoff","year":"2015","journal-title":"J Pain"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.mp.4000834","article-title":"Dissociating anxiety from pain: mapping the neuronal marker N-acetyl aspartate to perception distinguishes closely interrelated characteristics of chronic pain","volume":"6","author":"Grachev","year":"2001","journal-title":"Mol Psychiatry"},{"key":"ref7","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0166-4328(01)00431-4","article-title":"Dopamine dysfunction in AD\/HD: integrating clinical and basic neuroscience research","volume":"130","author":"Solanto","year":"2002","journal-title":"Behav Brain Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.psychres.2016.10.004","article-title":"ADHD symptoms and pain among adults in England","volume":"246","author":"Stickley","year":"2016","journal-title":"Psychiatry Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/papr.12129","article-title":"Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD)","volume":"15","author":"Treister","year":"2015","journal-title":"Pain Pract"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13034-016-0112-9","article-title":"Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate","volume":"10","author":"Wolff","year":"2016","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1744-9081-9-18","article-title":"Motor regulation problems and pain in adults diagnosed with ADHD","volume":"9","author":"Stray","year":"2013","journal-title":"Behav Brain Funct"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpain.2004.11.001","article-title":"Human brain mechanisms of pain perception and regulation in health and disease","volume":"9","author":"Apkarian","year":"2005","journal-title":"Eur J Pain"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.eurpsy.2017.01.002","article-title":"Age-related pharmacotherapy of attention deficit hyperactivity disorder in Slovenia in children and adolescents: A population-based study","volume":"42","author":"Stuhec","year":"2017","journal-title":"Eur Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1213\/01.ANE.0000133383.17666.3A","article-title":"Persistent pain as a disease entity: Implications for clinical management","volume":"99","author":"Siddall","year":"2004","journal-title":"Anesth Analg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0269881113519509","article-title":"British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology","volume":"28","author":"Bolea-Alama\u00f1ac","year":"2014","journal-title":"J Psychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1060028018795703","article-title":"Efficacy, acceptability, and tolerability of Lisdexamfetamine, mixed amphetamine salts, methylphenidate, and Modafinil in the treatment of attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis","volume":"53","author":"Stuhec","year":"2019","journal-title":"Ann Pharmacother"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.jcp.0000108984.11879.95","article-title":"Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit\/hyperactivity disorder","volume":"24","author":"Faraone","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1097\/PR9.0000000000000593","article-title":"Methylphenidate attenuates the response to cold pain but not to aversive auditory stimuli in healthy human: a double-blind randomized controlled study","volume":"2","author":"Pud","year":"2017","journal-title":"Pain Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/02699052.2013.865267","article-title":"Evaluation of dosage, safety and effects of methylphenidate on post-traumatic brain injury symptoms with a focus on mental fatigue and pain","volume":"28","author":"Johansson","year":"2014","journal-title":"Brain Inj"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/apa.14220","article-title":"A case report and literature review of autism and attention deficit hyperactivity disorder in paediatric chronic pain","volume":"107","author":"Wiwe Lipsker","year":"2018","journal-title":"Acta Paediatr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"ref23","volume-title":"ADHD rating scale-IV: Checklists, norms, and clinical interpretation. Japanese version (Ichikawa H, Tanaka Y, Trans.)","author":"DuPaul","year":"2008"},{"key":"ref24","volume-title":"Adult intelligence scale--third edition (WAIS-III). Japanese version (Fujita K, Maekawa H, Dairoku K, Yamanaka K, Publication committee)","author":"Wechsler","year":"2006"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"PCC.13r01600","DOI":"10.4088\/PCC.13r01600","article-title":"Underdiagnosis of attention-deficit\/hyperactivity disorder in adult patients: a review of the literature","volume":"16","author":"Ginsberg","year":"2014","journal-title":"Prim Care companion CNS Disord"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1017\/S0033291708003309","article-title":"The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm","volume":"39","author":"Kessler","year":"2009","journal-title":"Psychol Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/PSY.0000000000000789","article-title":"Attention-deficit\/hyperactivity disorder and chronic pain","volume":"82","author":"Kasahara","year":"2020","journal-title":"Psychosom Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e181152","DOI":"10.1001\/jamanetworkopen.2018.1152","article-title":"Prevalence of and factors associated with long-term concurrent use of stimulants and opioids among adults with attention-deficit\/hyperactivity disorder","volume":"1","author":"Wei","year":"2018","journal-title":"JAMA Netw Open"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s0166-2236(02)02157-4","article-title":"Chronic pain and medullary descending facilitation","volume":"25","author":"Porreca","year":"2002","journal-title":"Trends Neurosci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1212\/01.wnl.0000318225.51122.63","article-title":"Descending monoaminergic pain modulation: bidirectional control and clinical relevance","volume":"71","author":"Benarroch","year":"2008","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1523\/JNEUROSCI.3481-14.2015","article-title":"Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1\/D5-mediated mechanism","volume":"35","author":"Kim","year":"2015","journal-title":"J Neurosci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/j.pain.0000000000001414","article-title":"Dopamine receptor D2, but not D1, mediates descending dopaminergic pathway-produced analgesic effect in a trigeminal neuropathic pain mouse model","volume":"160","author":"Liu","year":"2019","journal-title":"Pain"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1586\/14737175.8.5.781","article-title":"Role of central dopamine in pain and analgesia","volume":"8","author":"Wood","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0304-3959(98)00003-7","article-title":"Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy","volume":"75","author":"Ertas","year":"1998","journal-title":"Pain"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0304-3959(00)00409-7","article-title":"Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study","volume":"90","author":"J\u00e4\u00e4skel\u00e4inen","year":"2001","journal-title":"Pain"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jpain.2006.05.014","article-title":"Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study","volume":"8","author":"Wood","year":"2007","journal-title":"J Pain"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/j.1460-9568.2007.05623.x","article-title":"Fibromyalgia patients show an abnormal dopamine response to pain","volume":"25","author":"Wood","year":"2007","journal-title":"Eur J Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"110717","DOI":"10.1016\/j.mehy.2021.110717","article-title":"Neuroinflammation as a possible link between attention-deficit\/hyperactivity disorder (ADHD) and pain","volume":"157","author":"Kerekes","year":"2021","journal-title":"Med Hypotheses"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.2174\/1570159X17666190430102531","article-title":"Role of descending dopaminergic pathways in pain modulation","volume":"17","author":"Li","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"RC121","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001","article-title":"Therapeutic doses of Oral methylphenidate significantly increase extracellular dopamine in the human brain","volume":"21","author":"Volkow","year":"2001","journal-title":"J Neurosci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainresbull.2013.03.004","article-title":"Dose response effect of methylphenidate on ventral tegmental area neurons and animal behavior","volume":"96","author":"Jones","year":"2013","journal-title":"Brain Res Bull"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.biopsych.2010.06.017","article-title":"Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo","volume":"68","author":"Hannestad","year":"2010","journal-title":"Biol Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/10582450802161960","article-title":"Use of Atomoxetine in a patient with fibromyalgia syndrome and attention-deficit hyperactivity disorder","volume":"16","author":"Vorobeychik","year":"2008","journal-title":"J Musculoskeletal Pain"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/brainsci10100701","article-title":"Association between chronic pain and alterations in the mesolimbic dopaminergic system","volume":"10","author":"Yang","year":"2020","journal-title":"Brain Sci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biopsych.2019.10.018","article-title":"The mesolimbic dopamine system in chronic pain and associated affective comorbidities","volume":"87","author":"Serafini","year":"2020","journal-title":"Biol Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/nn.3811","article-title":"Reward and motivation in pain and pain relief","volume":"17","author":"Navratilova","year":"2014","journal-title":"Nat Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pain.2006.10.004","article-title":"The amygdala: different pains","volume":"127","author":"Neugebauer","year":"2007","journal-title":"Diff. Mech. Pain"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12264-016-0016-y","article-title":"Insular cortex is critical for the perception, modulation, and Chronification of pain","volume":"32","author":"Lu","year":"2016","journal-title":"Neurosci Bull"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1002\/hbm.24053","article-title":"Anterior insula hyperactivation in ADHD when faced with distracting negative stimuli","volume":"39","author":"Vetter","year":"2018","journal-title":"Hum Brain Mapp"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.pain.2010.11.010","article-title":"Pain and the brain: specificity and plasticity of the brain in clinical chronic pain","volume":"152","author":"Apkarian","year":"2011","journal-title":"Pain"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.neuroimage.2008.09.008","article-title":"Altered brain activity during pain processing in fibromyalgia","volume":"44","author":"Burgmer","year":"2009","journal-title":"NeuroImage"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/1087054709351671","article-title":"Anterior cingulate volumetric alterations in treatment-na\u00efve adults with ADHD: a pilot study","volume":"13","author":"Makris","year":"2010","journal-title":"J Atten Disord"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2147\/ndt.s2627","article-title":"Attention-deficit-hyperactivity disorder and reward deficiency syndrome","volume":"4","author":"Blum","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neubiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"Faraone","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1016\/j.neuroimage.2010.10.060","article-title":"Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls","volume":"54","author":"Tomasi","year":"2011","journal-title":"NeuroImage"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.33549\/physiolres.933535","article-title":"The effect of combined treatment of opioids with methylphenidate on nociception in rats and pain in human","volume":"65","author":"Yamamotov\u00e1","year":"2016","journal-title":"Physiol Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4088\/pcc.v04n0404","article-title":"Comorbid psychiatric disorders and predictors of pain management program success in patients with chronic pain","volume":"4","author":"Workman","year":"2002","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e0242865","DOI":"10.1371\/journal.pone.0242865","article-title":"Disentangling comorbidity in chronic pain: a study in primary health Care settings from India","volume":"15","author":"Desai","year":"2020","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4088\/pcc.v02n0502","article-title":"Methylphenidate abuse and psychiatric side effects","volume":"2","author":"Morton","year":"2000","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"884055","DOI":"10.3389\/fpain.2022.884055","article-title":"Editorial: placebo effect in pain and pain treatment","volume":"3","author":"Bernstein","year":"2022","journal-title":"Front Pain Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1091399\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T04:23:37Z","timestamp":1678422217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1091399\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":60,"alternative-id":["10.3389\/fpsyt.2023.1091399"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1091399","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"article-number":"1091399"}}